Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Faith Ough"'
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Table S1. Inter-tumor heterogeneity of T-cell densities in tumor microenvironment in dMMR vs pMMR stage III colon cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1923e7a7b6d7f8a7a4c8f7968dcac9
https://doi.org/10.1158/1078-0432.22473723
https://doi.org/10.1158/1078-0432.22473723
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Figure S1 Study flow of N0147 patient tumor samples Figure S2 Heterogeneity of lymphocytic infiltrate between patients in mismatch repair deficient (dMMR) and proficient (pMMR) tumors. The distribution of T-cell densities (score 0-100) are shown as f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::269fb33d6305dda3d848d9497f687eb0
https://doi.org/10.1158/1078-0432.22473729.v1
https://doi.org/10.1158/1078-0432.22473729.v1
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Table S3: Association between T-cell subtypes and covariates in MMR-deficient and -proficient stage III colon cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a9dbcc8ee531d3c0831a4277c6e20a
https://doi.org/10.1158/1078-0432.22473717
https://doi.org/10.1158/1078-0432.22473717
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Table S2: Association between immune T-cell subtypes in MMR-deficient and -proficient stage III colon cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad55102e3a4781f4870b58fde44b97f8
https://doi.org/10.1158/1078-0432.22473720.v1
https://doi.org/10.1158/1078-0432.22473720.v1
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Table S4. Identification of optimal cutpoint in CD3+ T-cell densities at the invasive margin (CD3+IM) to distinguish overall survival in mismatch repair-deficient stage IIII colon cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb6698b7f7bd48c8322698b4d6562aa
https://doi.org/10.1158/1078-0432.22473714
https://doi.org/10.1158/1078-0432.22473714
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Purpose:Colorectal cancers with deficient DNA mismatch repair (dMMR) are presumed to uniformly have dense lymphocytic infiltration that underlies their favorable prognosis and is critical to their responsiveness to immunotherapy, as compared with MMR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3f8547b2d1f14a6c49b48586bc0ae3
https://doi.org/10.1158/1078-0432.c.6528582
https://doi.org/10.1158/1078-0432.c.6528582
Autor:
Frank A. Sinicrope, Kandavel Shanmugam, Steven R. Alberts, Michael Barnes, Wen-Wei Liu, Rebecca Bowermaster, June Clements, Azita Djalilvand, Faith Ough, Joerg Bredno, Andrea Muranyi, Erica N. Heying, Qian Shi, Harry H. Yoon
Table S5. Identification of optimal cutpoint in CD3+ T-cell densities at the invasive margin (CD3+IM) to distinguish overall survival in mismatch repair-proficient stage IIII colon cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a906d84c84d04da5b0a08eb7c560720
https://doi.org/10.1158/1078-0432.22473711.v1
https://doi.org/10.1158/1078-0432.22473711.v1
Autor:
Harry H, Yoon, Qian, Shi, Erica N, Heying, Andrea, Muranyi, Joerg, Bredno, Faith, Ough, Azita, Djalilvand, June, Clements, Rebecca, Bowermaster, Wen-Wei, Liu, Michael, Barnes, Steven R, Alberts, Kandavel, Shanmugam, Frank A, Sinicrope
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(1)
BACKGROUND: Colorectal cancers with deficient DNA mismatch repair (dMMR) are presumed to uniformly have dense lymphocytic infiltration that underlies their favorable prognosis and is critical to their responsiveness to immunotherapy, as compared to M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::944990cd353e20ce9bed37358bbd76a3
https://pubmed.ncbi.nlm.nih.gov/30301825
https://pubmed.ncbi.nlm.nih.gov/30301825
Autor:
Tanja Pejovic, Damanzoopinder Samrao, Nicole Turner, Yvonne G. Lin, Song Liu, Paulette Mhawech-Fauceglia, Faith Ough, Annie A. Yessaian, Dan Wang, Teodulo Menesses
Publikováno v:
Translational Oncology. 5:469-474
The use of neoadjuvant chemotherapy followed by tumor reduction surgery, also called interval debulking surgery (IDS), is considered an alternative therapeutic regimen for selected patients with advanced stage epithelial ovarian cancer (EOC). Althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb66430e885ae36161fdb2b5f68d489
https://doi.org/10.1593/tlo.12265
https://doi.org/10.1593/tlo.12265
Autor:
Heidi Godoy, Dan Wang, Faith Ough, Tanja Pejovic, Damanzoopinder Samrao, Shashikant Lele, Paulette Mhawech-Fauceglia, Song Liu
Objectives Pair-Box 8 ( PAX8 ) is a transcription factor which has been found to be overexpressed in ovarian serous carcinoma (OSC). Silencing PAX8 by using shRNA led to a drop in cell viability in ovarian cancer cell lines, suggesting its use as a t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::974b9cd37d6b300c7310799698f03f24
https://europepmc.org/articles/PMC5049509/
https://europepmc.org/articles/PMC5049509/